Skip to main content

Advertisement

SpringerLink
Log in

Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients

  • Clinical Investigation
  • Interventional Oncology
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To retrospectively review outcomes in patients treated for colorectal liver metastases with DEBIRI.

Materials and Methods

A retrospective analysis of patients with CRLM treated with DEBIRI was performed between 2008 and 2017 between two tertiary centres. Outcome parameters were overall survival and hepatic progression-free survival, as well as safety. Subgroup analyses were performed to assess the impact on outcomes of hepatic tumour burden at time of treatment, the presence of extrahepatic disease, prior systemic chemotherapy and the prior administration of systemic irinotecan-containing chemotherapy.

Results

Fifty-three patients received 125 treatments with DEBIRI over the study period. Median age of patients was 71 (range 41–88). Patients previously received a median of 1 line of chemotherapy (range 1–5). Median number of DEBIRI treatments was 2 (range 1–6). The median survival from first treatment was 14.5 months (range 1–107). Median hepatic progression-free survival was 5 months (0–86.5 months). The presence of extrahepatic disease (seen in 45% of patients) correlated with lower OS. Prolonged OS was seen in patients who received previous ablation and systemic chemotherapy. Technical success rate was found to be 99%. Post-procedural complication rate was 6%.

Conclusion

Our findings add to the growing body of literature to support the safety profile of DEBIRI in the treatment of CRLM. Further studies will be necessary to help establish the optimum berth of DEBIRI in the treatment algorithm for colorectal liver metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr. Accessed 1 July 2018.

  2. Gruber-Rouh T, Naguib N, Eichler K, et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer. 2014;134(5):1225–31. https://doi.org/10.1002/ijc.28443.

    Article  CAS  PubMed  Google Scholar 

  3. Fong Y, Blumgart LH. Hepatic colorectal metastasis: current status of surgical therapy. Oncology. 1998;12:1489–503.

    CAS  PubMed  Google Scholar 

  4. Aliberti C, Tilli M, Benea G, Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res. 2006;26:3793–5.

    CAS  PubMed  Google Scholar 

  5. Akinwande O, Scoggins C, Martin RC. Early experience with 70–150 μm irinotecan drug-eluting beads (M1-DEBIRI) for the treatment of unresectable hepatic colorectal metastases. Anticancer Res. 2016;36(7):3413–8.

    CAS  PubMed  Google Scholar 

  6. Martin R, Scoggins C, Schreeder M, et al. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. Cancer. 2015;121(20):3649–58.

    Article  CAS  PubMed  Google Scholar 

  7. Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O’Grady E, Rilling WS, Walker D, Martin RC. Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. J Vasc Interv Radiol. 2014;25(3):365–9. https://doi.org/10.1016/j.jvir.2013.11.027.

    Article  PubMed  Google Scholar 

  8. Fiorentini G, Aliberti C, Tilli M, et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res. 2012;32(4):1387–95.

    CAS  PubMed  Google Scholar 

  9. Stutz M, Mamo A, Valenti D, et al. Real-life report on chemoembolization using DEBIRI for liver metastases from colorectal cancer. Gastroenterol Res Pract. 2015;2015:715102. https://doi.org/10.1155/2015/715102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Huppert P, Wenzel T, Wietholtz H. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population. Cardiovasc Intervent Radiol. 2014;37(1):154–64. https://doi.org/10.1007/s00270-013-0632-0.

    Article  PubMed  Google Scholar 

  11. Martin R, Robbins K, Tomalty D, et al. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol. 2009;7:80. https://doi.org/10.1186/1477-7819-7-80.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bhutiani N, Akinwande O, Martin R. Efficacy and toxicity of hepatic intra-arterial drug-eluting (Irinotecan) Bead (DEBIRI) therapy in irinotecan-refractory unresectable colorectal liver metastases. World J Surg. 2016;40(5):1178–90. https://doi.org/10.1007/s00268-015-3386-9.

    Article  PubMed  Google Scholar 

  13. Akinwande O, Philips P, Duras P, Pluntke S, Scoggins C, Martin R. Small versus large-sized drug-eluting beads (DEBIRI) for the treatment of hepatic colorectal metastases: a propensity score matching analysis. Cardiovasc Intervent Radiol. 2015;38(2):361–71. https://doi.org/10.1007/s00270-014-1011-1.

    Article  PubMed  Google Scholar 

  14. Young S, D’Souza D, Flanagan S, et al. Review of the clinical evidence for the use of DEBIRI in the treatment of colorectal metastatic disease. Cardiovasc Intervent Radiol. 2017;40:496. https://doi.org/10.1007/s00270-016-1537-5.

    Article  PubMed  Google Scholar 

  15. Liu D, Thakor A, Baerlocher M, Alshammari M, Lim H, et al. A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof. Future Oncol. 2015;11(9):1421–8. https://doi.org/10.2217/fon.15.3.

    Article  CAS  PubMed  Google Scholar 

  16. Richardson A, Laurence J, Lam V. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review. J Vasc Interv Radiol. 2013;24(8):1209–17. https://doi.org/10.1016/j.jvir.2013.05.055.

    Article  PubMed  Google Scholar 

  17. Fiorentini G, Aliberti C, Turrisi G, et al. Intra-arterial hepatic chemoembolisation of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase III clinical study. Vivo. 2007;21(1085):1092.

    Google Scholar 

  18. Watchmaker J, Lipnik A, Fritsche M, Baker J, Mouli S, Geevarghese S, Banovac F, Omary R, Brown D. Are prophylactic antibiotics necessary prior to transarterial chemoembolization for hepatocellular carcinoma in patients with native biliary anatomy? J Surg Oncol. 2018;117(6):1312–7. https://doi.org/10.1002/jso.24993.

    Article  CAS  PubMed  Google Scholar 

  19. Woo S, Chung J, Hur S, Joo S, Kim H, Jae H, Park J. Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors. AJR Am J Roentgenol. 2013;200(6):1370–7. https://doi.org/10.2214/AJR.12.9630.

    Article  PubMed  Google Scholar 

  20. Spreafico C, Cascella T, Facciorusso A, Sposito C, Rodolfo L, Morosi C, Civelli EM, Vaiani M, Bhoori S, Pellegrinelli A, Marchianò A, Mazzaferro V. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile. Cardiovasc Intervent Radiol. 2015;38(1):129–34. https://doi.org/10.1007/s00270-014-0907-0.

    Article  PubMed  Google Scholar 

  21. Deipolyi AR, Oklu R, Al-Ansari S, Zhu A, Goyal L, Ganguli S. Safety and efficacy of 70–150 μm and 100–300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2015;26(4):516–22.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Interventional Radiology, Royal Liverpool and Broadgreen University Hospital, Prescot St, Liverpool, L7 8XP, UK

    An Ngo, Beniamino Corbo, Jonathan Evans & Nabil Kibrya

  2. Interventional Oncology Service, University College Hospital, 235 Euston Road, London, NW1 2BU, UK

    Conrad von Stempel, Steve Bandula, Jowad Raja & Julian Hague

  3. Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK

    Steve Bandula

  4. Department of Oncology, University College Hospital, 235 Euston Road, London, NW1 2BU, UK

    Kai Keen Shiu

Authors
  1. An Ngo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Conrad von Stempel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beniamino Corbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steve Bandula
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kai Keen Shiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jowad Raja
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julian Hague
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jonathan Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nabil Kibrya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to An Ngo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and Animal Rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed Consent

For this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 34 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ngo, A., von Stempel, C., Corbo, B. et al. Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients. Cardiovasc Intervent Radiol 42, 979–990 (2019). https://doi.org/10.1007/s00270-019-02219-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-019-02219-4

Keywords

Search

Navigation